Form 4: Lucira Health, Inc. (LHDX), Hartmann Hansgregory C., transaction 03/10/2021

Summary

Hansgregory C. Hartmann, Chief Operating Officer of Lucira Health, Inc. [ LHDX ], reports 70,000 shares of Common Stock acquired on 03/10/2021 at no cost, representing a Restricted Stock Unit award, which is also the full direct holding afterward. Under the footnote, 23,328 shares vest on October 1, 2021 and the remainder in equal monthly installments of 2,917 shares on the 18th of each month, from October 18, 2021 through January 18, 2023. The form is signed /s/ Dan George, Attorney-in-Fact for Hansgregory C. Hartmann, 03/10/2021.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Full text

SEC Form 4

FORM 4 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB APPROVAL | OMB Number: 3235-0287 Estimated average burden hours per response: 0.5 | OMB Number: | 3235-0287 | Estimated average burden | hours per response: | 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person * HARTMANN HANSGREGORY C. (Last) (First) (Middle) C/O LUCIRA HEALTH, INC. 1412 62ND STREET (Street) EMERYVILLE CA 94608 (City) (State) (Zip) | HARTMANN HANSGREGORY C. | (Last) | (First) | (Middle) | C/O LUCIRA HEALTH, INC. | 1412 62ND STREET | EMERYVILLE | CA | 94608 | (City) | (State) | (Zip) | 2. Issuer Name and Ticker or Trading Symbol Lucira Health, Inc. [ LHDX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Operating Officer | Director | 10% Owner | X | Officer (give title below) | Other (specify below) | Chief Operating Officer
3. Date of Earliest Transaction
 (Month/Day/Year) 03/10/2021
4. If Amendment, Date of Original Filed
 (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | X | Form filed by One Reporting Person | Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr.
 3) | 2. Transaction Date
 (Month/Day/Year) | 2A. Deemed Execution Date, if any
 (Month/Day/Year) | 3. Transaction Code (Instr.
 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr.
 3, 4 and 5) | 5.
 Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 7. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | Amount | (A) or (D) | Price
Common Stock | 03/10/2021 | A | 70,000 (1) | A | $ 0.00 | 70,000 | D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.
 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date
 (Month/Day/Year) | 3A. Deemed Execution Date, if any
 (Month/Day/Year) | 4. Transaction Code (Instr.
 8) | 5.
 Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.
 3, 4 and 5) | 6. Date Exercisable and Expiration Date
 (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr.
 3 and 4) | 8. Price of Derivative Security (Instr.
 5) | 9.
 Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr.
 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr.
 4) | 11. Nature of Indirect Beneficial Ownership (Instr.
 4)
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares
Explanation of Responses:
1. Represents shares underlying Restricted Stock Unit award that will vest with respect to 23,328 shares on October 1, 2021 and the remainder will vest in equal monthly installments of 2,917 shares vesting on the 18th day of each calendar month that occurs thereafter, commencing on October 18, 2021 and ending on January 18, 2023.
Remarks:
/s/ Dan George, Attorney-in-Fact for Hansgregory C. Hartmann | 03/10/2021
** Signature of Reporting Person | Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
 4

 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

File and source

File

SEC_LHDX_4_filed2021-03-10_0001209191-21-019651.xml

Size

15,294 bytes

SHA-256

0e74cc206cb59b1286088e376d3744466dc0b070dc3098c3e15c20649c328ded

Our copy

SEC_LHDX_4_filed2021-03-10_0001209191-21-019651.xml

Original

www.sec.gov